23.69
前日終値:
$25.01
開ける:
$24.88
24時間の取引高:
783.71K
Relative Volume:
0.53
時価総額:
$3.50B
収益:
-
当期純損益:
$-151.09M
株価収益率:
-15.19
EPS:
-1.56
ネットキャッシュフロー:
$-160.51M
1週間 パフォーマンス:
-6.47%
1か月 パフォーマンス:
-16.91%
6か月 パフォーマンス:
+72.42%
1年 パフォーマンス:
+35.37%
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
名前
Centessa Pharmaceuticals Plc Adr
セクター
電話
44 7391 789784
住所
3RD FLOOR, ALTRINCHAM, CHESHIRE
CNTA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CNTA
Centessa Pharmaceuticals Plc Adr
|
23.69 | 3.70B | 0 | -151.09M | -160.51M | -1.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-10 | 再開されました | Oppenheimer | Outperform |
| 2025-10-28 | 開始されました | Stephens | Overweight |
| 2025-09-03 | 開始されました | Wells Fargo | Overweight |
| 2025-08-29 | 再開されました | Oppenheimer | Outperform |
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-05-28 | 開始されました | Needham | Buy |
| 2025-05-08 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-31 | 開始されました | Piper Sandler | Overweight |
| 2025-01-07 | 開始されました | TD Cowen | Buy |
| 2024-09-20 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | 開始されました | B. Riley Securities | Buy |
| 2024-07-18 | 開始されました | Oppenheimer | Outperform |
| 2023-11-15 | アップグレード | Jefferies | Hold → Buy |
| 2023-10-26 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | 開始されました | Evercore ISI | Outperform |
| 2023-06-12 | 開始されました | Guggenheim | Buy |
| 2023-03-17 | 開始されました | SVB Securities | Outperform |
| 2022-08-12 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
| 2022-06-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-02-11 | 開始されました | Goldman | Neutral |
すべてを表示
Centessa Pharmaceuticals Plc Adr (CNTA) 最新ニュース
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap DownHere's What Happened - MarketBeat
Armistice Capital LLC Lowers Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
oracle, visa among market cap stock movers on thursday By Investing.com - Investing.com UK
oracle, visa among market cap stock movers on thursday - Investing.com India
Russell Investments Group Ltd. Has $1.85 Million Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa stock falls on CEO transition announcement By Investing.com - Investing.com South Africa
Top investors say Centessa Pharmaceuticals plc ADR (CNTA) ticks everything they need - setenews.com
Stempoint Capital LP Increases Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Accardi sells Centessa (CNTA) shares worth $288,288 - Investing.com
Centessa Pharma president sells shares for $300,000 By Investing.com - Investing.com South Africa
Analysts Boost Centessa Pharmaceuticals plc (CNTA) Price Targets as Sleep Disorder Drug Shows Breakthrough Results - Finviz
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 10,000 Shares of Stock - MarketBeat
Centessa Pharma president sells shares for $300,000 - Investing.com India
100,362 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Purchased by Bollard Group LLC - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Hits New 1-Year HighStill a Buy? - MarketBeat
Affinity Asset Advisors LLC Sells 646,500 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals stock hits all-time high at 29.99 USD By Investing.com - Investing.com Nigeria
Centessa Pharmaceuticals stock hits all-time high at 29.99 USD - Investing.com
Saturn V Capital Management LP Acquires 344,635 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
B. Riley Research Analysts Raise Earnings Estimates for CNTA - MarketBeat
OMERS ADMINISTRATION Corp Buys New Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
American Century Companies Inc. Raises Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
B. Riley Analysts Boost Earnings Estimates for CNTA - Defense World
Centessa Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:CNTA) - MarketBeat
Healthy Upside Potential: Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
What is Palisade Bio Inc (PALI) Stock Return on Shareholders’ Capital? - setenews.com
Grupo Supervielle S.A. ADR (SUPV) looking to reclaim success with recent performance - Setenews
The growth track for Tron Inc (TRON) has changed recently - Setenews
Taking the lead: Argo Blockchain Plc ADR (ARBK) - Setenews
Check out these key findings about Polestar Automotive Holding UK PLC ADR (PSNY) - Setenews
There is no way Rezolve AI PLC (RZLV) can keep these numbers up - Setenews
Check out these key findings about Nova Minerals Limited ADR (NVA) - Setenews
Check Out INVO Fertility Inc (IVF)’s Trade Data Rather Than the Analysts’ Views - Setenews
An analyst sees good growth prospects for Can-Fite Biopharma Ltd ADR (CANF) - Setenews
Meridian Wealth Partners LLC Invests $501,000 in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Stocks of Klarna Group plc (KLAR) are poised to climb above their peers - Setenews
Its Stock Has Paid Off Big Time For Aptera Motors Corp - Setenews
It makes sense and dollars to buy ATA Creativity Global ADR (AACG) stock - Setenews
Check out these key findings about Hub Cyber Security Ltd (HUBC) - Setenews
A better buy-in window may exist right now for Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Views of Wall Street’s Leading Experts on Liminatus Pharma Inc - Setenews
Investors in cash trouble should check out Bonk Inc (BNKK) - Setenews
Centessa (CNTA) launches $250M ATM ADS offering via Leerink - Stock Titan
Brokers Set Expectations for CNTA FY2025 Earnings - Defense World
Prepare Yourself for Liftoff: Seadrill Ltd (SDRL) - setenews.com
Centessa Pharmaceuticals stock hits all-time high at 29.31 USD By Investing.com - Investing.com Nigeria
Centessa Pharmaceuticals stock hits all-time high at 29.31 USD - Investing.com
Stevanato Group Spa (STVN) looking to reclaim success with recent performance - setenews.com
CNTA: Phase 2 data show best-in-class efficacy and safety for orexin agonists in sleep disorders - TradingView
Centessa Pharmaceuticals Plc Adr (CNTA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):